One of the most telling—and chilling—incidents in the past year for the biotechnology industry was the Mttle-noted, intellectual free-for-all experienced by a handful of U.S. observers attending a meeting of signatories to the ill-starred biodiversity treaty in Nairobi early last July. Although successive polls have shown astonishing levels of misunderstanding among educated people even in industrialized countries about "biotechnology" and "genetic engineering," there was little to prepare these U.S. biotech specialists for the performance of incomprehensibility that attended discussion in the Kenyan capital.
展开▼
